Empowered Funds, LLC Eli Lilly & CO Transaction History

Empowered Funds, LLC

$6.17 Billion
Q3 2024

A detailed history of Empowered Funds, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Empowered Funds, LLC holds 31,796 shares of LLY stock, worth $25 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

31,796

Previous 33,316 4.56%

Holding current value

$25 Million

Previous $30.2 Million 6.61%

% of portfolio

0.46%

Previous 0.54%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$772.14 - $960.02 $1.17 Million - $1.46 Million	-1,520 Reduced 4.56%	31,796 $28.2 Million
Q2 2024 Jul 30, 2024	BUY	$724.87 - $909.04 $934,357 - $1.17 Million	1,289 Added 4.02%	33,316 $30.2 Million
Q1 2024 May 06, 2024	BUY	$592.2 - $792.28 $5.73 Million - $7.67 Million	9,681 Added 43.32%	32,027 $24.9 Million
Q3 2023 Nov 01, 2023	BUY	$434.7 - $599.3 $636,400 - $877,375	1,464 Added 7.01%	22,346 $12 Million
Q2 2023 Jul 27, 2023	SELL	$350.74 - $468.98 $2.55 Million - $3.41 Million	-7,268 Reduced 25.82%	20,882 $9.79 Million
Q1 2023 Apr 05, 2023	BUY	$310.63 - $364.82 $879,082 - $1.03 Million	2,830 Added 11.18%	28,150 $9.67 Million
Q4 2022 Jan 26, 2023	BUY	$321.55 - $374.67 $5.37 Million - $6.26 Million	16,701 Added 193.77%	25,320 $9.26 Million
Q3 2022 Nov 04, 2022	SELL	$296.48 - $337.87 $791,305 - $901,775	-2,669 Reduced 23.64%	8,619 $2.79 Million
Q2 2022 Aug 01, 2022	BUY	$278.73 - $327.27 $1.9 Million - $2.23 Million	6,812 Added 152.19%	11,288 $3.66 Million
Q1 2022 Apr 21, 2022	BUY	$234.69 - $291.66 $119,691 - $148,746	510 Added 12.86%	4,476 $1.28 Million
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $141,655 - $175,795	630 Added 18.88%	3,966 $1.1 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $257,056 - $316,343	1,160 Added 53.31%	3,336 $771,000
Q2 2021 Aug 04, 2021	BUY	$180.55 - $233.54 $392,876 - $508,183	2,176 New	2,176 $499,000
Q3 2019 Nov 01, 2019	SELL	$106.79 - $116.16 $1.04 Million - $1.13 Million	-9,719 Closed	0 $0
Q2 2019 Jul 09, 2019	SELL	$110.79 - $129.32 $216,151 - $252,303	-1,951 Reduced 16.72%	9,719 $1.08 Million
Q1 2019 May 10, 2019	BUY	$111.31 - $131.02 $1.3 Million - $1.53 Million	11,670 New	11,670 $1.51 Million

Others Institutions Holding LLY

# of Institutions

3,994

Shares Held

752M

Call Options Held

7.31M

Put Options Held

9.23M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $747B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Empowered Funds, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empowered Funds, LLC with notifications on news.

Account

Empowered Funds, LLC Eli Lilly & CO Transaction History